화이트 바이오테크 시장 : 예측(2026-2031년)

Global White Biotech Market, with a 8.33% CAGR, is forecasted to grow from USD 334.755 billion in 2025 to USD 541.097 billion in 2031.

The white biotechnology market, encompassing industrial biotechnology, is defined by the application of living cells-such as microorganisms, plant cells, and enzymes-to create sustainable products and processes. This sector stands as a cornerstone of the modern bioeconomy, offering environmentally favorable alternatives to conventional petrochemical-based production across a diverse range of industries including biofuels, bioplastics, pharmaceuticals, fine chemicals, and industrial enzymes.

A paramount driver for market expansion is the global imperative to reduce carbon emissions and environmental impact. As industries and governments intensify efforts to mitigate climate change, white biotech provides a critical pathway for decarbonization. Its processes typically consume less energy, generate reduced waste, and yield biodegradable end-products compared to traditional manufacturing. This fundamental alignment with sustainability goals is creating robust demand for bio-based solutions as viable replacements for fossil fuel-derived materials, positioning white biotech as an essential technology for industrial transformation.

Concurrently, significant governmental support and strategic policy initiatives are accelerating market development worldwide. National and regional governments are increasingly recognizing the strategic importance of fostering a strong bioeconomy. Through direct investments, research grants, and supportive regulatory frameworks, public policy is actively de-risking innovation and scaling up bio-based manufacturing capacities. This top-down support is crucial for building the necessary infrastructure and stimulating private sector investment across the value chain.

Technological advancement forms the bedrock of the sector's progress, with continuous innovation in genetic engineering and process optimization. The ability to precisely modify microorganisms-enhancing their efficiency, yield, and ability to produce novel compounds-is a key enabler. Advances in genetic modification techniques, alongside improvements in fermentation technology and biocatalyst design, are continually expanding the commercial feasibility and scope of white biotech applications. These innovations are lowering production costs and enabling the manufacture of more complex, high-value products.

From a regional perspective, the Asia Pacific market is emerging as a dominant and high-growth area. This trajectory is fueled by a combination of large, expanding populations, rapid industrialization, and proactive government policies aimed at promoting sustainable development. Nations within the region are implementing initiatives to build domestic biotech capabilities, reduce reliance on imported fossil resources, and address pressing environmental challenges. The region's substantial manufacturing base and growing focus on circular economy principles provide a fertile ground for the adoption and scaling of industrial biotechnology solutions.

The market's broad application across multiple strategic industries underscores its economic significance and resilience. White biotech is not confined to a single sector but is integral to transformative shifts in energy (biofuels), materials (bioplastics), health (pharmaceuticals and enzymes), and agriculture. This diversification mitigates risk and ensures that growth is fueled by cross-industrial trends toward sustainability and supply chain security. The technology's role in creating drop-in replacements as well as entirely novel materials solidifies its position as a versatile industrial platform.

In conclusion, the white biotechnology market is being propelled by a powerful convergence of environmental necessity, policy support, and scientific innovation. The urgent global focus on reducing carbon footprints provides a compelling, long-term demand driver, while governmental bioeconomy strategies are providing essential momentum. Continuous advancements in genetic and process engineering are expanding the technical and commercial horizons of what is possible. With the Asia Pacific region poised for substantial growth due to its demographic and economic scale, the white biotech market is strategically positioned at the intersection of industrial productivity and ecological sustainability, poised for continued integration into the global manufacturing landscape.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

White Biotech Market Segmentation

• By Microorganism Type
• Yeast
• Bacteria
• Others
• By Application
• Biofuels
• Bioplastic
• Biochemicals
• Others
• By End-User
• Chemicals
• Food & Beverage
• Power & Energy
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WHITE BIOTECH MARKET BY MICROGRANISM TYPE

• 5.1. Introduction
• 5.2. Yeast
• 5.3. Bacteria
• 5.4. Others

6. WHITE BIOTECH MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Biofuels
• 6.3. Bioplastic
• 6.4. Biochemicals
• 6.5. Others

7. WHITE BIOTECH MARKET BY END-USER

• 7.1. Introduction
• 7.2. Chemicals
• 7.3. Food & Beverage
• 7.4. Power & Energy
• 7.5. Others

8. WHITE BIOTECH MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Microorganism Type
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Microorganism Type
  • 8.3.2. By Application
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Microorganism Type
  • 8.4.2. By Application
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. Germany
    • 8.4.4.2. France
    • 8.4.4.3. United Kingdom
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Microorganism Type
  • 8.5.2. By Application
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Microorganism Type
  • 8.6.2. By Application
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. India
    • 8.6.4.3. Japan
    • 8.6.4.4. South Korea
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Thailand
    • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Cargill Incorporated
• 10.2. DuPont
• 10.3. DSM-Firmenich
• 10.4. BASF SE
• 10.5. Evonik Industries AG
• 10.6. Laurus Labs
• 10.7. Corbion NV
• 10.8. Novonesis
• 10.9. ADM
• 10.10. Lonza Group Ltd

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations